checkAd
PerkinElmer Aktie
 
Handeln Smartbroker Aktionen
159,45
 
EUR
10:04:15 Tradegate
+0,95 %
+1,50 EUR
Geldkurs 10:07:01
156,55 EUR
58 Stk.
Briefkurs 10:07:01
159,35 EUR
57 Stk.

Video Nachrichten

PerkinElmer Prices Offering of Senior Notes

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that it has priced an offering of $500.0 million aggregate principal amount of 0.550% Senior Notes due 2023 at an issue price of 99.964% of …

Wertpapier:
PerkinElmer to Present at 2021 Baird Global Healthcare Conference

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the virtual Baird Global Healthcare Conference on Tuesday, September 14, 2021 at 10:50 a.m. ET. Steve …

Wertpapier:

Nachrichten

DatumTitel
26.07.21PerkinElmer Announces Financial Results for the Second Quarter of 2021
Business Wire (engl.) | Weitere Nachrichten
26.07.21PerkinElmer to Acquire Antibody and Reagent Leader BioLegend
Business Wire (engl.) | Weitere Nachrichten
23.07.21PerkinElmer Board Declares Quarterly Dividend
Business Wire (engl.) | Weitere Nachrichten
24.06.21PerkinElmer Provides Update on Second Quarter Performance and Schedules Earnings Call for Wednesday, July 28, 2021
Business Wire (engl.) | Weitere Nachrichten
22.06.21PerkinElmer Agrees to Acquire Viral Vector Gene Delivery Leader SIRION Biotech
Business Wire (engl.) | Weitere Nachrichten
17.05.21PerkinElmer to Acquire In-Vitro Diagnostics Company Immunodiagnostic Systems Holdings PLC
Business Wire (engl.) | Weitere Nachrichten
12.05.21PerkinElmer Expands Cell Biology Leadership with Agreement to Acquire Nexcelom Bioscience
Business Wire (engl.) | Weitere Nachrichten
04.05.21PerkinElmer to Host Virtual Investor and Analyst Day
Business Wire (engl.) | Weitere Nachrichten
04.05.21PerkinElmer Announces Financial Results for the First Quarter of 2021
Business Wire (engl.) | Weitere Nachrichten
29.04.21PerkinElmer Board Declares Quarterly Dividend
Business Wire (engl.) | Weitere Nachrichten
29.04.21Oxford Immunotec’s T-SPOT Discovery SARS-CoV-2 Test Used in DIRECT Study to Investigate the T Cell Response and COVID Vaccination in Ethnic Minority Groups
globenewswire | Weitere Nachrichten
27.04.21Oxford Immunotec’s T-SPOT Discovery SARS-CoV-2 Test is Used in UK Com-COV Clinical Trial to Investigate the T Cell Response in Different Combinations of Approved COVID-19 Vaccines for the First and Second Doses
globenewswire | Weitere Nachrichten
21.04.21PerkinElmer to Present at BofA Securities 2021 Virtual Health Care Conference
Business Wire (engl.) | Weitere Nachrichten
13.04.21 PerkinElmer Provides First Quarter Update and Schedules Earnings Call for Tuesday, May 4, 2021
Business Wire (engl.) | Weitere Nachrichten
30.03.21Horizon Discovery erweitert sein Genmodulations-Portfolio um die branchenweit erste synthetische Single Guide RNA und den zum Patent angemeldeten dCas9-Repressor für CRISPRi
Business Wire (dt.) | Weitere Nachrichten